Brief: NRx Pharmaceuticals Reports Q2 Net Loss Of $7.0 Million Compared With A Net Loss Of $0.1 Million
Aug 15 (Reuters) - NRX Pharmaceuticals Inc NRXP.O :
* NRX PHARMACEUTICALS PROVIDES BUSINESS UPDATE AND REPORTS
SECOND
QUARTER 2022 RESULTS FOCUSING ON REACTIVATION & ADVANCEMENT OF
ITS PSYCHIATRY FRANCHISE
* NRX PHARMACEUTICALS INC QTRLY NET LOSS WAS $7.0 MILLION
COMPARED
WITH A NET LOSS OF $0.1 MILLION
* NRX PHARMACEUTICALS INC - COMPLETED MANUFACTURE OF PHASE
3/COMMERCIAL READY ZYESAMI
Source text for Eikon: ID:nPn4s1P07a
Further company coverage: NRXP.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on NRX Pharmaceuticals
See all newsBrief: NRx Pharmaceuticals Reschedules Conference Call To Discuss Third Quarter And Year To Date 2024 Financial Results To November 18, 2024
U.S. RESEARCH ROUNDUP-Cintas Corp, Sprouts Farmers market, Voya Financial
U.S. STOCKS ON THE MOVE-Molson Coors, Starbucks, Warner Bros Discovery
U.S. STOCKS ON THE MOVE-Zebra Technologies, Ecolab, American Electric Power
NRX Pharmaceuticals Inc expected to post a loss of 7 cents a share - Earnings Preview